Pancreatic Cancer Staging Systems and their Clinical Impact

The Pancreas: An Integrated Textbook of Basic Science, Medicine, and Surgery: Second Edition

Volumn , Issue , 2009, Pages 678-681

  Beger, Hans G ^a   Birk, Dieter ^b  

^a UNIVERSITY HOSPITAL ULM   (Germany)

^b Evang Krankenhaus Zweibrücken   (Germany)

Author keywords

American Joint Committee for Cancer Classification (AJCC); Immunohistologic and PCR techniques detection methods; JPS based on TNM (tumor, node, metastasis) system; Pancreatic cancer dissemination pattern; Pancreatic cancer staging systems and clinical impact; Stage of metastasis classification M0, no distant metastases; M1, distant metastases present; and Mx, cannot be assessed; UICC 2003 classification for pancreatic cancer tumor size, lymph node involvement; Union Internationale Contra le Cancer (UICC) and Japanese Pancreas Society (JPS)

Indexed keywords

EID: 84889872072     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781444300123.ch69     Document Type: Chapter

References (28)

1. Wittekind Ch, Meyer HJ, Bootz F. TNM Classification Maligner Tumoren. Heidelberg: Springer-Verlag, 2003: 86-88.
2. Japanese Pancreas Society. Classification of Pancreatic Carcinoma, 2nd English edn. Tokyo: Kanehara & Co., 2002.
3. Tsuchiya R, Oribe T, Noda T. Size of the tumor and other factors influencing prognosis of carcinoma of the head of the pancreas. Am J Gastroenterol 1985;80:459.
4. Cameron JL, Crist DW, Sitzmann JV et al. Factors influencing survival after pancreaticoduodenectomy for pancreatic cancer. Am J Surg 1991;161:120.
5. Nagakawa T, Kayahar M, Ohta T et al. Patterns of neural and plexus extensive invasion of human pancreatic cancer and experimental cancer. Int J Pancreatol 1991;10:113.
6. Ishikawa O. Surgical technique, curability and postoperative quality of life in an extended pancreatectomy for adenocarcinoma of the pancreas. Hepatogastroenterology 1996;43:320.
7. Geer RJ, Brennan MF. Prognostic indicators for survival after resection of adenocarcinoma of the pancreas. Am J Surg 1993;165:68.
8. Yeo C, Abrams R, Grochow L et al. Pancreaticoduodenectomy for pancreatic adenocarcinoma: postoperative adjuvant chemoradiation improves survival. Ann Surg 1997;225:621.
9. Takahashi T, Ishikara H, Kato H, Tanabe T, Yoshiki T. Intrapancreatic, extratumoral perineural invasion. Acta Pathol Jpn 1992;42:99-103.
10. Kayahara M, Nagakawa T, Futagami F et al. Lymphatic flow and neural plexus invasion associated with carcinoma of the body and tail of the pancreas. Cancer 1996;78:2485-2491.
11. Heeckt P, SafiF, Binder T, Büchler M. Free intraperitoneal tumor cells in pancreatic cancer: significance for clinical course and therapy. H Det Chirurg 1992;63:563-7.
12. Kayahar M, Nagakawa T, Konishi I, Ueno K, Ohta T, Miyazaki I. Clinicopathological study of pancreatic carcinoma with particular reference to the invasion of the extrapancreatic neural plexus. Int J Pancreatol 1991;10:105-11.
13. Nagakawa T, Kayahara M, Ueno K et al. A clinicopatholgic study on neural invasion in cancer of the pancreatic head. Cancer 1992;69:930-5.
14. Nakao A, Harada A, Nonami T, Kaneko T, Takagi H. Clinical significance of carcinoma invasion of the extrapancreatic nerve plexus in pancreatic cancer. Pancreas 1996;12:357-61.
15. Ohigashi H, Ishikawa O, Sasaki Y et al. K-ras point mutation in the nerve plexus arround superior mesenteric artery in resectable adenocarcinoma of the pancreatic head. Arch Surg 2000;135:1450-5.
16. Ando N, Nakao A, Nomoto S et al. Defection of mutant K-ras in dissected paraaortic lymph nodes of patients with pancreatic adenocarcinoma. Pancreas 1997;15:374-8.
17. Hosch SB, Knoefel WT, Metz S et al. Early lymphatic tumor cell dissemination in pancreatic cancer: frequency and prognostic significance. Pancreas 1997;15:154-9.
18. Demuere MJ, Doffek KM, Komoiowski RA, Wilson SD. Adenocarcinoma of the pancreas. Detection of occult metastases in regional lymph nodes by PCR-based assay. Cancer 1998;83: 1328-34.
19. Mühling B, Dehner C, Steiger et al. Micrometastasation in pancreatic head cancer: use of polymerase chain reaction for precise tumor staging. (unpublished data 2007)
20. Niedergethmann M, Rexin M, Hildenbrand R et al. Prognostic implications of routine, immunohistochemical, and molecular staging in resectable pancreatic adenocarcinoma. Am J Surg Pathol 2002;26:1578-87.
21. Tamagawa E, Ueda M, Takahashi S et al. Pancreatic lymph node and plexus micrometastases detected by enriched polymerase chain reaction and nonradioisotopic singlestrand conformation polymorphism analysis: a new predictive factor for recurrent pancreatic carcinoma. Clin Cancer Res 1997;3:2143-9.
22. Thorban S, Roder JD, Pantel K, Siewert JR. Epithelial tumour cells in bone marrow of patients with pancreatic carcinoma detected by immunocytochemical staining. Eur J Cancer 1996; 32A:363-5.
23. Thorban S, Roder JD, Siewert JR. Detection of micrometastasis in bone marrow of pancreatic cancer patients. Ann Oncol 1999;10(suppl 4):111-13.
24. Z'graggen K, Centeno BA, Fernandez del Castillo C, Jimenez RE, Werner J. Biological implications of tumor cells in blood and bone marrow of pancreatic cancer patients. Surgery 2001;129: 537-46.
25. Vogel I, Krüger U, Marxsen J et al. Disseminated tumor cells in pancreatic cancer patients detected by immunocytology: a new prognostic factor. Clin Cancer Res 1999;5:593-9.
26. Broll R, Weschta M, Windhoevel U et al. Prognostic significance of free gastrointestinal tumor cells in peritoneal lavage detected by immunocytochemistry and polymerase chain reaction. Langenbecks Arch Surg 2001;386:285-92.
27. Wittekind C, Compton CC, Greene FL, Sobin LH. TNM residual tumor classification revisited. Cancer 2002;94:2511-19.
28. Beger HG, Gansauge F, Birk D. Lymph node dissection. In: Cameron J, ed. Atlas of Clinical Oncology. Hamilton: BC Decker, 2001: 123-32.